BioAtla, Inc.BCABNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-15.9%
5Y CAGR+18.8%
Year-over-Year Change
Research and development spending
3Y CAGR
-15.9%/yr
vs +31.8%/yr prior
5Y CAGR
+18.8%/yr
Recent deceleration
Acceleration
-47.7pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $47.23M | -25.1% |
| 2024 | $63.09M | -39.2% |
| 2023 | $103.73M | +30.7% |
| 2022 | $79.35M | +36.2% |
| 2021 | $58.27M | +192.3% |
| 2020 | $19.93M | -23.1% |
| 2019 | $25.92M | -1.5% |
| 2018 | $26.30M | - |